SCHEMBL23675002

SCHEMBL23675002

CC1(C)CC(=O)Nc2cc(F)c(N)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 1/20 0.40
RARG P13631 1/20 0.40
TNKS O95271 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
HDAC3 O15379 6/20 0.36
HDAC4 P56524 5/20 0.36
HDAC1 Q13547 5/20 0.36
HDAC2 Q92769 5/20 0.36
HDAC8 Q9BY41 5/20 0.36
HDAC6 Q9UBN7 5/20 0.36
HDAC9 Q9UKV0 5/20 0.36
MAP3K5 Q99683 1/20 0.34
PGR P06401 7/20 0.34
CA9 Q16790 1/20 0.33
CYP19A1 P11511 1/20 0.32
HDAC7 Q8WUI4 1/20 0.30
HDAC10 Q969S8 1/20 0.30
HDAC11 Q96DB2 1/20 0.30
HDAC5 Q9UQL6 1/20 0.30
CMA1 P23946 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9379048 0.86 RARB (0.43) RARBRARGTNKSTNKS2HDAC3
SCHEMBL12428929 0.79 RARB (0.41) RARBRARGTNKSTNKS2HDAC3
SCHEMBL26443454 0.78 RARB (0.39) RARBRARGTNKSTNKS2HDAC3
SCHEMBL17276293 0.77 HDAC3 (0.41) RARBRARGTNKSTNKS2HDAC3
SCHEMBL29706774 0.77 HDAC3 (0.41) RARBRARGTNKSTNKS2HDAC3
SCHEMBL31714583 0.77 RARB (0.40) RARBRARGTNKSTNKS2HDAC3
SCHEMBL9379695 0.76 CYP1A2 (0.43) RARBRARGHDAC3HDAC4HDAC1
SCHEMBL23675078 0.76 PGR (0.43) RARBRARGTNKSTNKS2HDAC3
SCHEMBL29706809 0.76 MAP3K5 (0.44) RARBRARGTNKSTNKS2HDAC3
SCHEMBL2207230 0.75 RARB (0.41) RARBRARGHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 EP disclosed
WO-2021151062-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERISTY (US) 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PAH, ALDH2, IDH2 RARB 1405/4885RARG 1603/4885TNKS 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.